| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Biomarin Pharmaceutical Inc.'s insiders have reduced their positions by a net 17,557 shares worth roughly $1.2M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 214.6K | $11.95M | - | |
| CFO | 123.3K | $6.86M | - | |
| VP | 84.1K | $4.68M | - | |
| VP | 61.0K | $3.40M | - | |
| Dir | 49.4K | $2.75M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 9, 2017 | Daniel K Spiegelman59 | EVP, Chief Financial Officer | Sell | 5,000 | $90.00 | $450,000.00 | -21.6% | |
| Jan 9, 2017 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 8,000 | $88.49 | $707,920.00 | -4.5% | |
| Dec 30, 2016 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 8,000 | $83.60 | $668,760.00 | -4.5% | |
| Nov 25, 2016 | Henry J Fuchs | President, Worldwide R& D | Sale+OE | 15,000 | $87.40 | $1,310,988.00 | -11.6% | |
| Nov 22, 2016 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 139,487 | $86.62 | $12,082,992.56 | -45.0% | |
| Nov 18, 2016 | George Eric Davis65 | EVP, General Counsel | Sale+OE | 5,000 | $90.42 | $452,100.00 | -6.6% | |
| Nov 16, 2016 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 41,670 | $90.97 | $3,790,794.91 | -11.4% | |
| Nov 9, 2016 | V Bryan Lawlis53 | Director | Sale+OE | 7,500 | $95.00 | $712,500.00 | -35.1% | |
| Nov 9, 2016 | Daniel K Spiegelman59 | EVP, Chief Financial Officer | Sell | 20,000 | $90.61 | $1,812,206.00 | -46.4% | |
| Nov 8, 2016 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 140,000 | $82.67 | $11,574,241.00 | -30.2% |